The Aspen Italy decision: A "quick look" assessment leaves open questions
Skadden Arps Slate Meagher & Flom partner Ingrid Vandenborre and associate Stanislas de Villoutreys advise Aspen Pharmacare in relation to the ongoing proceeding of the European Commission that excludes Italy. In their commentary, they consider that the Aspen decision of Italy’s Competition Authority, upheld by the Regional Administrative Tribunal of Lazio’s judgment, has skipped the unfairness analysis set out by European Court of Justice in United Brands. The commentary is based on the Aspen decision and judgment as published.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.